Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 1,865.00
-25.00 (-1.32%)
Apr 29, 2026, 11:50 AM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 133.16 billion as of April 28, 2026. Its market cap has decreased by -31.09% in one year.
Market Cap
133.16B
Enterprise Value
231.99B
Revenue
41.98B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,865.00
Market Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 133.16B, a decrease of -43.86%. That is a compound annual growth rate of -4.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 133.16B | 34.57% |
| Dec 30, 2025 | 98.95B | -53.23% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 261.05B |
| JETEMA, | 260.84B |
| MedPacto | 188.17B |
| Macrogen | 183.22B |
| Vaxcell-Bio Therapeutics | 182.57B |
| ENCell | 181.64B |
| iNtRON Biotechnology | 119.66B |
| Oncocross | 107.81B |